Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × OTHER × Advanced Malignancies × Clear all

Phase

Status

Unknown 1 Recruiting 1

Sponsor Class

INDUSTRY 5 OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1428 Neoplasms 972 Colorectal Neoplasms 810 Carcinoma, Non-Small-Cell Lung 710 Carcinoma, Hepatocellular 677 Stomach Neoplasms 627 Lung Neoplasms 565 Prostatic Neoplasms 530 Pancreatic Neoplasms 440 Rectal Neoplasms 329 Uterine Cervical Neoplasms 299 Neoplasm Metastasis 294 Colonic Neoplasms 286 Ovarian Neoplasms 281 Recurrence 279 Esophageal Neoplasms 263 Leukemia, Myeloid, Acute 252 Head and Neck Neoplasms 234 Multiple Myeloma 231 Brain Neoplasms 202 Nasopharyngeal Carcinoma 199 Polycystic Ovary Syndrome 193 Melanoma 192 Precursor Cell Lymphoblastic Leukemia-Lymphoma 188 Urinary Bladder Neoplasms 186 Lymphoma 174 Liver Neoplasms 174 Endometrial Neoplasms 154 Motor Activity 139 Lymphoma, Large B-Cell, Diffuse 139

Interventions

Everolimus 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01079702 2010-03-03

m-TOR

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1/2 Unknown

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡